Exploration of olaparib resistance factors in BRCA1 knockout olaparib resistant cancer cells

被引：0
|
作者：
Sasaki, Yuka [1 ,2 ,3 ]
Masutani, Mitsuko [2 ,3 ]
Nakatsuka, Ryusuke [1 ]
Inouchi, Takuma [1 ]
Nozaki, Tadashige [1 ]
机构：
[1] Osaka Dent Univ, Dept Pharmacol, Osaka, Japan
[2] Nagasaki Univ, Dept Mol Genom Biomed, Nagasaki, Japan
[3] Nagasaki Univ, CBMM, Grad Sch Biomed Sci, Nagasaki, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1327
引用
收藏
页码：666 / 666
页数：1
相关论文
共 50 条
  • [1] Establishment of olaparib resistant clones from BRCA1 knockout cancer cells for the exploration of resistance genes.
    Sasaki, Yuka
    Nakatsuka, Ryusuke
    Inouchi, Takuma
    Masutani, Mitsuko
    Nozaki, Tadashige
    CANCER SCIENCE, 2023, 114 : 482 - 482
  • [2] Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells
    Sasaki, Yuka
    Inouchi, Takuma
    Nakatsuka, Ryusuke
    Inoue, Amane
    Masutani, Mitsuko
    Nozaki, Tadashige
    PLOS ONE, 2024, 19 (04):
  • [3] Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
    Burgess, Brian T.
    Anderson, Abigail M.
    McCorkle, J. Robert
    Wu, Jianrong
    Ueland, Frederick R.
    Kolesar, Jill M.
    DIAGNOSTICS, 2020, 10 (02)
  • [4] Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells
    Chiappa, Michela
    Guffanti, Federica
    Anselmi, Martina
    Lupi, Monica
    Panini, Nicolo
    Wiesmuller, Lisa
    Damia, Giovanna
    CANCERS, 2022, 14 (07)
  • [5] Olaparib for the treatment of relapsed ovarian cancer with a BRCA1/2 mutation
    Stewart, James
    George, Angela
    Banerjee, Susana
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (10) : 947 - 958
  • [6] Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells
    He, Wanhong
    Zhu, Haijun
    Zhang, Sufen
    Shu, Guang
    Lei, Han
    Wang, Maonan
    Yin, Gang
    Ni, Xiaohua
    Wu, Qihan
    EPIGENETICS, 2024, 19 (01)
  • [7] Transcriptional activation by BRCA1/ATF1 contributes to resistance to Olaparib.
    Endo, Shino
    Yoshino, Yuki
    Chiba, Natsuko
    CANCER SCIENCE, 2022, 113 : 926 - 926
  • [8] Exploring the mechanisms of olaparib resistance in resistant-BRCA1 deficient murine ovarian cells
    Chiappa, Michela
    Anselmi, Martina
    Russo, Luca
    Lupi, Monica
    Panini, Nicolo
    Guffanti, Federica
    Damia, Giovanna
    CANCER RESEARCH, 2022, 82 (12)
  • [9] BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis
    Pan, Jia-Ni
    Lei, Lei
    Ye, Wei-Wu
    Wang, Xiao-Jia
    Cao, Wen-Ming
    JOURNAL OF BREAST CANCER, 2021, 24 (05) : 474 - 480
  • [10] Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
    Kaufman, Bella
    Shapira-Frommer, Ronnie
    Schmutzler, Rita K.
    Audeh, M. William
    Friedlander, Michael
    Balmana, Judith
    Mitchell, Gillian
    Fried, Georgeta
    Stemmer, Salomon M.
    Hubert, Ayala
    Rosengarten, Ora
    Steiner, Mariana
    Loman, Niklas
    Bowen, Karin
    Fielding, Anitra
    Domchek, Susan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 244 - 250
12345